These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 15867602
1. Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition. Morrison CS, Richardson BA, Celentano DD, Chipato T, Mmiro F, Mugerwa R, Padian NS, Rugpao S, Salata RA. J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S17-8. PubMed ID: 15867602 [No Abstract] [Full Text] [Related]
2. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Nanda K, Morrison CS, Kwok C, Byamugisha J, Jones L, Sriplienchan S, Magwali T. Contraception; 2011 Jun; 83(6):542-8. PubMed ID: 21570552 [Abstract] [Full Text] [Related]
7. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies. Jain AK. Contraception; 2012 Dec 01; 86(6):645-52. PubMed ID: 22541635 [Abstract] [Full Text] [Related]
8. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness. Whiteman MK, Jeng G, Samarina A, Akatova N, Martirosyan M, Kissin DM, Curtis KM, Marchbanks PA, Hillis SD, Mandel MG, Jamieson DJ. Contraception; 2016 Jan 01; 93(1):17-24. PubMed ID: 26197261 [Abstract] [Full Text] [Related]
9. Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate. Hapgood JP. Endocrinology; 2013 Mar 01; 154(3):985-8. PubMed ID: 23429710 [No Abstract] [Full Text] [Related]
10. Hormonal contraception and the risk of HIV acquisition. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, Mugerwa R, Padian N, Rugpao S, Brown JM, Cornelisse P, Salata RA, Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV) Study Group. AIDS; 2007 Jan 02; 21(1):85-95. PubMed ID: 17148972 [Abstract] [Full Text] [Related]
11. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences. Levine JP. J Fam Pract; 2004 Nov 02; 53(11):904-13. PubMed ID: 15527729 [No Abstract] [Full Text] [Related]
12. The early work on hormonal contraceptive use and HIV acquisition. Martin HL, Richardson BA, Mandaliya K, Achola JO, Overbaugh J, Kreiss JK. J Acquir Immune Defic Syndr; 2005 Mar 02; 38 Suppl 1():S12-4. PubMed ID: 15867600 [No Abstract] [Full Text] [Related]
13. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women. Castilho JL, Jenkins CA, Shepherd BE, Bebawy SS, Turner M, Sterling TR, Melekhin VV. J Womens Health (Larchmt); 2015 Jun 02; 24(6):481-8. PubMed ID: 25751720 [Abstract] [Full Text] [Related]
14. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, Ndinya-Achola JO, Jaoko W, Overbaugh J. AIDS; 2007 Aug 20; 21(13):1771-7. PubMed ID: 17690576 [Abstract] [Full Text] [Related]
15. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. Lutalo T, Musoke R, Kong X, Makumbi F, Serwadda D, Nalugoda F, Kigozi G, Sewankambo N, Sekasanvu J, Wawer M, Gray R. AIDS; 2013 Oct 20; 27 Suppl 1():S27-34. PubMed ID: 24088681 [Abstract] [Full Text] [Related]
16. Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant: making decisions in the absence of evidence. Holman R, Stephen G. J Fam Plann Reprod Health Care; 2005 Oct 20; 31(4):333-4. PubMed ID: 16274569 [No Abstract] [Full Text] [Related]
17. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive. Jain JK, Ota F, Mishell DR. Contraception; 2000 Mar 20; 61(3):195-8. PubMed ID: 10827333 [Abstract] [Full Text] [Related]
18. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM. J Adolesc Health; 2004 Dec 20; 35(6):434-41. PubMed ID: 15581522 [Abstract] [Full Text] [Related]